Questions to Ask Your Doctor After a Colorectal Cancer Diagnosis

A colorectal cancer diagnosis can bring uncertainty about treatment, recovery, and what comes next. Understanding where the cancer is located, how far it has spread, and which treatment options are appropriate can help you take an active role in decisions about your care. Preparing questions before an appointment can also make it easier to discuss concerns that might otherwise be overlooked.

Colon cancer and rectal cancer share many characteristics, but their evaluation and treatment can differ. The following questions can help guide conversations with your medical team, whether you are newly diagnosed, preparing for surgery, considering additional treatment, or planning follow-up care.

Understanding Your Colorectal Cancer Diagnosis

1. What type of colorectal cancer do I have, and where is it located?

Most colorectal cancers are adenocarcinomas, which develop from glandular cells in the lining of the colon or rectum. Less common tumors can arise in the same region but may require different approaches to diagnosis and treatment. Your pathology report identifies the type of cancer found in the tissue sample.

The precise location also matters. A tumor in the colon may be managed differently from one in the rectum, particularly when surgery, radiation therapy, or treatment before surgery is being considered. Ask your doctor to explain your diagnosis and show you where the tumor is located.

2. What is the stage of my cancer, and has it spread?

Staging describes how far cancer has developed within the bowel wall, whether nearby lymph nodes are involved, and whether cancer has spread to distant organs. The stage helps guide treatment recommendations and discussions about prognosis.

Evaluation may include imaging, pathology review, blood tests, and other procedures. Rectal cancer often requires specialized pelvic imaging to evaluate the tumor’s relationship to nearby structures. In some cases, the final pathological stage is determined after surgery, when the removed tissue and lymph nodes can be examined.

Ask which staging information is already available, whether additional tests are needed, and how the findings affect your treatment options.

3. Has my tumor been tested for biomarkers or inherited cancer risk?

Colorectal cancers may have molecular characteristics that influence treatment decisions. Testing for mismatch repair deficiency (dMMR) or high microsatellite instability (MSI-H) can help identify patients who may benefit from certain immunotherapies. Additional testing for changes involving genes such as KRAS, NRAS, or BRAF may be appropriate, particularly in advanced disease.

Some test results can also raise the possibility of Lynch syndrome, an inherited condition associated with increased risks of colorectal and certain other cancers. Tumor testing does not by itself establish an inherited diagnosis, and genetic counseling or additional testing may be recommended based on the findings and family history.

Ask which tests have been completed, whether additional molecular testing is needed, and how the results may affect treatment or cancer screening recommendations for family members.

Choosing a Colorectal Cancer Treatment Plan

4. What treatments do you recommend, and why?

Colorectal cancer treatment may involve surgery, chemotherapy, radiation therapy, immunotherapy, targeted medications, or a combination of approaches. The recommended plan depends on whether the cancer is in the colon or rectum, its stage, tumor characteristics, and your overall health.

For many localized colon cancers, surgery is an important initial treatment, sometimes followed by chemotherapy. Selected patients with locally advanced rectal cancer may receive chemotherapy, radiation therapy, or other treatment before surgery. Certain patients with tumors showing dMMR or MSI-H may be candidates for immunotherapy in specific clinical settings.

Ask what the goal of each treatment is, why the recommended sequence is appropriate, and what alternatives may be available.

5. Will I need surgery, and how might it affect bowel function?

Surgery for colorectal cancer generally involves removing the tumor along with an appropriate portion of surrounding bowel and nearby lymph nodes. Depending on the location and extent of disease, the remaining sections of the bowel may be reconnected. Some patients require an ostomy, in which bowel contents pass through an opening in the abdominal wall into a collection pouch.

An ostomy may be temporary or permanent, depending on the operation and clinical circumstances. Surgery involving the rectum can also affect bowel habits, continence, and other aspects of pelvic function. These potential changes deserve discussion before treatment.

Ask which surgical approach is recommended, whether minimally invasive or robot-assisted surgery is appropriate, and what the likely effects on bowel function and recovery may be.

6. Will I need chemotherapy, radiation therapy, or immunotherapy?

Not every patient needs the same combination of treatments. Chemotherapy may be recommended before or after surgery or used to help control advanced disease. Radiation therapy is more commonly used for selected rectal cancers than for colon cancers, particularly when local tumor control is important.

Immunotherapy and targeted treatments may be appropriate for certain cancers with specific molecular characteristics. Whether these treatments are recommended depends on the clinical evidence for the patient’s stage, tumor biology, and treatment setting.

Ask why a particular treatment is recommended, how its potential benefits compare with its risks, and whether it may affect the timing or extent of surgery.

7. Should I consider a clinical trial or a second opinion?

Clinical trials investigate new treatments, combinations of established therapies, and approaches to improving cancer care. Depending on your diagnosis and treatment history, a study may be appropriate before treatment begins or at another point in your care.

A second opinion can also help you understand complex treatment choices, particularly when several approaches are reasonable or major surgery is being considered. Seeking another opinion does not necessarily mean delaying treatment, although the appropriate timing should be discussed with your physicians.

Ask whether an available clinical trial is suitable for your diagnosis and whether additional specialist input could help clarify your options.

Learn more about Active Clinical Trials at Saint John’s Cancer Institute.

Preparing for Treatment and Recovery

8. What side effects or changes in daily life should I expect?

Cancer treatment can affect digestion, appetite, energy, bowel habits, physical activity, and the ability to work or carry out daily responsibilities. The possible effects vary according to the treatment selected. Surgery may require a recovery period and adjustments to bowel function, while chemotherapy, radiation, and other systemic treatments can produce different short- or long-term side effects.

Some treatments may also affect sexual function or fertility. Patients who hope to have children in the future should discuss fertility preservation before beginning treatments that may affect reproductive health.

Ask which side effects are most relevant to your treatment plan, what symptoms require urgent attention, and whom to contact after hours if problems develop.

9. What supportive care services are available to me and my family?

A colorectal cancer diagnosis may affect emotional well-being, nutrition, mobility, finances, employment, and relationships. Supportive care services can help patients and families address these concerns alongside cancer treatment.

At Providence Saint John’s Health Center, Cancer Support Services includes psycho-oncology, oncology social work, nutritional counseling, rehabilitation, survivorship care, and other programs. Depending on individual needs, these services may help with emotional distress, nutrition during treatment, recovery after surgery, or practical challenges that interfere with care.

Ask your care team whether supportive services are appropriate for you and how referrals or appointments are arranged.

Explore Cancer Support Services for more information about available resources.

10. What follow-up care will I need after treatment?

Follow-up care after colorectal cancer treatment helps monitor recovery, manage ongoing treatment effects, and look for signs that cancer may have returned. Depending on the diagnosis, stage, and treatment received, follow-up may include physical examinations, blood tests, imaging, colonoscopy, or other evaluations.

Some patients benefit from additional rehabilitation, nutritional counseling, or support for changes in bowel function. Patients with hereditary cancer risk may also need a different long-term screening plan.

Ask how frequently follow-up appointments will occur, which tests are recommended, what symptoms to report, and who will coordinate your care after active treatment ends.

Making the Most of Your Colorectal Cancer Consultation

It may help to bring a written list of questions, copies of relevant medical records, medication information, and a family member or trusted person who can assist with taking notes. Ask for explanations of unfamiliar medical terms and request copies of important test results, including pathology and biomarker reports.

You do not have to ask every question during a single appointment. Prioritize the issues most important to you, including decisions that need to be made soon, and discuss how to reach the care team if additional questions arise.

For a deeper understanding of your diagnosis, visit our Colorectal Cancer Conditions page. For more information about surgery, systemic therapies, radiation, and individualized treatment planning, explore Colorectal Cancer Treatment.

Questions Are an Important Part of Your Care

Understanding your diagnosis and treatment options can help you make informed decisions about colorectal cancer care. Your questions matter, whether they concern the medical details of treatment, its effects on daily life, or the support you and your family may need along the way.

The team at Saint John’s Cancer Institute can help you explore the next steps in evaluation and treatment. Learn more through our Center for Gastrointestinal and Hepatobiliary Tumors or call 310-449-5206.

Sources & Further Reading

About the Author

Dr. Anton Bilchik

Anton J. Bilchik, M.D., Ph.D., MBA, FACS, is the Professor of Surgery, Chief of General Surgery, and Director of Gastrointestinal and Hepatobiliary Program at the Saint John’s Cancer Institute. Anton J. Bilchik, MD is an internationally recognized surgeon and scientist who has pioneered techniques to improve staging cancer and minimally invasive approaches to improve outcomes. Learn More About Dr. Anton Bilchik.